Search Close Search
Search Close Search
Page Menu

UMass Chan Medical School strives to catalyze our world-class basic research into scientific discoveries with high impact clinical applications and overcome the barriers in translating knowledge into clinical practice.

Established in 1970, UMass Chan has rapidly grown into a highly productive, highly collaborative research enterprise with outstanding scientific resources and facilities. UMass Chan receives more than $300 million per year in research funding. Our research community includes a Nobel laureate, a Lasker award recipient, seven National Academy members and four Howard Hughes Medical Institute investigators. Our research achievements have impacted the lives of children and adults in the U.S. and across the globe.

Research news

Getting Results…
  • UMass Chan Medical School visit fosters collaboration with Dubai Health

    UMass Chan Medical School visit fosters collaboration with Dubai Health

    UMass Chan Medical School and Dubai Health signed a memorandum of understanding to establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the institutions, and drive transformative advancements for public health locally and globally.  

    Read more
  • UMass Chan neurobiology chair Danny Winder to help lead new Vanderbilt alcohol use disorder center

    UMass Chan neurobiology chair Danny Winder to help lead new Vanderbilt alcohol use disorder center

    The Vanderbilt AUD Research and Education Center is funded in part by a five-year, $8.9 million grant from the National Institutes of Health.

    Read more
  • Mary Munson, Craig Peterson named American Association for the Advancement of Science fellows

    Mary Munson, Craig Peterson named American Association for the Advancement of Science fellows

    The two UMass Chan faculty members are among 500 scientists, engineers and innovators elected this year.

    Read more
  • Drugs that aren’t antibiotics can also kill bacteria; new method pinpoints how

    Drugs that aren’t antibiotics can also kill bacteria; new method pinpoints how

    Mariana Noto Guillen, a PhD candidate in the lab of Amir Mitchell, PhD, associate professor of systems biology, wrote an article for The Conversation explaining a recent Science paper about how nonantibiotics have sufficient antibacterial activity to affect gut microbiome composition. It explains what nonantibiotics are, and the mechanisms behind their antibacterial effects.  

    Read more
  • UMass Chan, Temple collaborate on rehabilitation research and training center for youth

    UMass Chan, Temple collaborate on rehabilitation research and training center for youth

    The new center will focus on advancing community living and participation outcomes for young adults from disadvantaged, marginalized and vulnerable populations who have serious mental health conditions.

    Read more
  • Massachusetts Secretary of Economic Development Yvonne Hao announced a $555,000 grant from the Massachusetts Technology Collaborative to UMass Chan on April 10, to be matched with $137,000 private investment, for the establishment of the Health AI Assurance Laboratory, in partnership with MITRE and the Coalition for Health AI. Pictured at the announcement, from left to right: Francis Campion, MITRE; Ozgur Eris, MITRE; Brian Anderson, CHAI; Carolyn Kirk, MassTech; Patrick Larkin, MassTech; Secretary Yvonne Hao; Terence R. Flotte, UMass Chan; Michael F. Collins, UMass Chan; Senator Robyn Kennedy; Doug Robbins, MITRE; Melissa Fischer, UMass Chan; Miles Thompson, MITRE; David McManus, UMass Chan.

    UMass Chan and MITRE launch Health AI Assurance Laboratory with MassTech grant

    UMass Chan Medical School and MITRE, operator of federally funded research and development centers, announced the establishment of the Health AI Assurance Laboratory, a collaborative initiative to advance health artificial intelligence in the public interest. The initiative is at the forefront of efforts in the United States, and the first in Massachusetts, to ensure AI technology in health care is safe and effective for everyone using it.

    Read more